1. Home
  2. GBIO vs OGI Comparison

GBIO vs OGI Comparison

Compare GBIO & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • OGI
  • Stock Information
  • Founded
  • GBIO 2016
  • OGI 2013
  • Country
  • GBIO United States
  • OGI Canada
  • Employees
  • GBIO N/A
  • OGI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • OGI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GBIO Health Care
  • OGI Health Care
  • Exchange
  • GBIO Nasdaq
  • OGI Nasdaq
  • Market Cap
  • GBIO 29.5M
  • OGI 231.9M
  • IPO Year
  • GBIO 2020
  • OGI N/A
  • Fundamental
  • Price
  • GBIO $5.77
  • OGI $1.77
  • Analyst Decision
  • GBIO Buy
  • OGI
  • Analyst Count
  • GBIO 4
  • OGI 0
  • Target Price
  • GBIO $10.67
  • OGI N/A
  • AVG Volume (30 Days)
  • GBIO 76.7K
  • OGI 704.1K
  • Earning Date
  • GBIO 11-05-2025
  • OGI 08-13-2025
  • Dividend Yield
  • GBIO N/A
  • OGI N/A
  • EPS Growth
  • GBIO N/A
  • OGI N/A
  • EPS
  • GBIO N/A
  • OGI 0.05
  • Revenue
  • GBIO $21,230,000.00
  • OGI $164,107,753.00
  • Revenue This Year
  • GBIO N/A
  • OGI $59.31
  • Revenue Next Year
  • GBIO N/A
  • OGI $15.12
  • P/E Ratio
  • GBIO N/A
  • OGI $35.24
  • Revenue Growth
  • GBIO 61.15
  • OGI 50.01
  • 52 Week Low
  • GBIO $3.00
  • OGI $0.85
  • 52 Week High
  • GBIO $29.10
  • OGI $2.00
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 50.66
  • OGI 67.85
  • Support Level
  • GBIO $5.51
  • OGI $1.56
  • Resistance Level
  • GBIO $6.04
  • OGI $1.70
  • Average True Range (ATR)
  • GBIO 0.32
  • OGI 0.07
  • MACD
  • GBIO -0.10
  • OGI 0.01
  • Stochastic Oscillator
  • GBIO 26.80
  • OGI 87.50

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About OGI Organigram Holdings Inc.

Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

Share on Social Networks: